Rickets Market Research Report – Forecast till 2027

Rickets Market Research Report, By Types (Vitamin D-Related Rickets, Hypocalcemia-Related Rickets, Hypophosphatemia-Related Rickets), Causes (Sunlight, Diet, Genetics), Therapy (Diagnosis, Treatment), End Users (Hospital, Clinics) - Forecast till 2027

ID: MRFR/Pharma/3250-HCR | February 2021 | Region: Global | 90 pages

Rickets Market Scenario:


Rickets is a condition characterised by the deficiency of Vitamin D that affects bone development in children which can lead to bone deformities. Rickets in adults is known as osteomalacia. The disease causes softening of the bones, bone pain, poor growth and deformities of the skeleton, such as bowed legs, curvature of the spine, and thickening of the ankles, wrists and knees. According to the Vitamin D Council, in 2016, approximately 1 billion individuals worldwide, which is nearly 15% of the world’s population, are vitamin D deficient or insufficient i.e. suffering from rickets. Increasing prevalence of rickets, poor diet and changing lifestyle have driven the growth of the rickets market. In the recent decades, the number of patients suffering from rickets is increasing continuously. Smoking is considered as one of the risk factors of rickets. According to the Centers for Disease Control and Prevention, cigarette smoking is the leading cause of death in the United States, accounting for over 480,000 deaths every year. Moreover, increasing healthcare expenditure, increasing geriatric population, and increasing demand for vitamin D supplements have fuelled the growth of the market. Strong encouragement from the government have also contributed to the growth of the rickets market. However, lack of presided treatment and high cost of the drugs and supplements may lead to hinder the growth of the rickets market.


The rickets market is expected to grow at a CAGR of 9.86% during forecast period.


Intended Audience



  • Pharmaceutical companies

  • Biotechnological institutes

  • Government and Private Laboratories

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers


Figure 1:- Global Rickets market share, by causes Rickets Market


Sources: WHO, annual reports, press release, white paper, and company presentation


Segmentation


The rickets market is segmented on the basis of types, causes, therapy, and end users.


On the basis of types, the rickets market is segmented into vitamin D-related rickets, hypocalcemia-related rickets, hypophosphatemia-related rickets, and others. Vitamin D-related rickets is further segmented into vitamin D deficiency, and vitamin D-dependent rickets. Hypophosphatemia-related rickets is further segmented into congenital, hypophosphatemia, Fanconi's syndrome, and others.


On the basis of causes, the rickets market is categorised into sunlight, diet, genetics and others


On the basis of therapy, the rickets market is segmented into diagnosis and treatment. Diagnosis is further segmented into blood tests, bone density scan, radiography, and others. Treatment is subsegmented into diet & sunlight therapy, supplementation, and others.


On the basis of end users, the rickets market is segmented into hospital, clinics, and others. 


Regional Analysis


America dominates the rickets market owing to a well-developed healthcare sector and huge demand for vitamin supplements. Apart from this, increasing number of patients, changing lifestyle and increasing healthcare expenditure have boosted the growth of the market in America. According to a research, approximately 35% of the U.S. population has vitamin D deficiency. Additionally, increasing geriatric population, increasing smoking population and increasing awareness among the people regarding different types of diseases and well-developed technology has also contributed to the growth of the rickets market.


Europe is the second largest rickets market, which is followed by Asia Pacific. Availability of funds for research, huge patient population and government support for research & development will drive the rickets market. In recent years, there's been an increase in cases of rickets in the UK. The number of rickets cases is still relatively small. Around 700 cases were diagnosed in hospitals in England in 2014, however a significant number of people in the UK have low levels of vitamin D in their blood.


Asia Pacific is the fastest growing region for the rickets market due to the presence of a huge patient population, continuously developing economies, and presence of huge opportunity in the rickets market.


On the other hand, the Middle East & Africa has the least share in the rickets market due to presence of poor economy especially in Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure. 


Research Methodology
Rickets Market-


Sources: WHO, annual reports, press release, white paper, and company presentation 


Key players for rickets market


The key players for the rickets market are Koninklijke DSM N.V. (the Netherlands), Nestlé S.A. (Switzerland), ADM Alliance Nutrition, Inc. (U.S.), Groupe Danone S.A. (France), Abbott (U.S.), Kraft Foods Group, Inc. (U.S.), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pfizer (U.S.), and Sun Pharmaceutical Industries Ltd (India)



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   9.86% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Types, Causes, Therapy, and End Users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Koninklijke DSM N.V. (the Netherlands), Nestlé S.A. (Switzerland), ADM Alliance Nutrition, Inc. (U.S.), Groupe Danone S.A. (France), Abbott (U.S.), Kraft Foods Group, Inc. (U.S.), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pfizer (U.S.), and Sun Pharmaceutical Industries Ltd (India)
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing prevalence of rickets
  • Poor diet
  • Changing lifestyle
  • Increasing healthcare expenditure
  • Increasing geriatric population
  • Increasing demand for vitamin D supplements


  • Speak to Analyst Ask for Customization

    TABLE OF CONTENT

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Rickets Market, by Type

    6.1 Introduction

    6.2 Vitamin D-Related Rickets

    Market Estimates & Forecast, 2020 – 2027

    6.2.1 Vitamin D Deficiency

    6.2.2 Vitamin D-Dependent Rickets

    6.3 Hypocalcemia-Related Rickets

    Market Estimates & Forecast, 2020 – 2027

    6.4 Hypophosphatemia-Related Rickets

    Market Estimates & Forecast, 2020 – 2027

    6.4.1 Congenital

    6.4.2 Hypophosphatemia

    6.4.3 Fanconi's Syndrome

    6.4.4 Others

    6.5 Others

    Chapter 7. Global Rickets Market, by Causes

    7.1 Introduction

    7.2 Sunlight

    Market Estimates & Forecast, 2020 – 2027

    7.3 Diet

    Market Estimates & Forecast, 2020 – 2027

    7.4 Genetics

    Market Estimates & Forecast, 2020 – 2027

    7.5 Others

    Market Estimates & Forecast, 2020 – 2027

    Chapter 8. Global Rickets Market, by Therapy

    8.1 Introduction

    8.2 Diagnosis

    Market Estimates & Forecast, 2020 – 2027

    8.2.1 Blood Tests

    8.2.2 Bone Density Scan

    8.2.3 Radiography

    8.2.4 Others

    8.3 Treatment

    Market Estimates & Forecast, 2020 – 2027

    8.3.1 Diet & Sunlight Therapy

    8.3.2 Supplementation

    8.3.3 Others

    Chapter 9 Global Rickets Market, by End User

    9.1 Introduction

    9.2 Hospitals

    9.2.1 Market Estimates & Forecast, 2020 – 2027

    9.3 Clinics

    9.2.2 Market Estimates & Forecast, 2020 – 2027

    9.4 Others

    Chapter 10. Global Rickets Market, by Region

    10.1 Introduction

    10.2 America

    10.2.1 North America

    10.2.1.1 US

    10.2.1.1 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 Italy

    10.3.1.4 Spain

    10.3.1.5 UK

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 Republic of Korea

    10.4.6 Rest of Asia Pacific

    10.5 The Middle East & Africa

    10.5.1 United Arab Emirates

    10.5.2 Saudi Arabia

    10.5.3 Oman

    10.5.4 Kuwait

    10.5.5 Qatar

    10.5.6 Rest of the Middle East & Africa

    Chapter 11 Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    11.3.1 Key Developments

    Chapter 12 Company Profiles

    12.1 Koninklijke DSM N.V.

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials

    12.1.4 SWOT Analysis

    12.2 Nestlé S.A.

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 ADM Alliance Nutrition, Inc.

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Groupe Danone S.A.

    12.4.1 Company Overview

    12.4.2 Product/Business Segment Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 Abbott

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial overview

    12.5.4 Key Developments

    12.6 Merck & Co., Inc.

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.7 F. Hoffmann-La Roche Ltd.

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financials

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 Others

    Chapter 13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s View Point

    13.1.2 Unmet Needs of the Market

    13.2 Key Companies to Watch

    13.3 Prediction of Pharmaceutical industry

    Chapter 14 Appendix

    LIST OF TABLES

    Table 1 Rickets Industry Synopsis, 2020 – 2027

    Table 2 Global Rickets Market Estimates and Forecast, 2020 – 2027, (USD Million)

    Table 3 Global Rickets Market by Region, 2020 – 2027, (USD Million)

    Table 4 Global Rickets Market by Types, 2020 – 2027, (USD Million)

    Table 5 Global Rickets Market by Causes, 2020 – 2027, (USD Million)

    Table 6 Global Rickets Market by Therapy, 2020 – 2027, (USD Million)

    Table 7 Global Rickets Market by End Users, 2020 – 2027, (USD Million)

    Table 8 North America Rickets Market by Types, 2020 – 2027, (USD Million)

    Table 9 North America Rickets Market by Causes, 2020 – 2027, (USD Million)

    Table 10 North America Rickets Market by Therapy, 2020 – 2027, (USD Million)

    Table 11 North America Rickets Market by End Users, 2020 – 2027, (USD Million)

    Table 12 US Market by Types, 2020 – 2027, (USD Million)

    Table 13 US Rickets Market by Causes, 2020 – 2027, (USD Million)

    Table 14 US Rickets Market by Therapy, 2020 – 2027, (USD Million)

    Table 15 US Rickets Market by End Users, 2020 – 2027, (USD Million)

    Table 16 Canada Market by Types, 2020 – 2027, (USD Million)

    Table 17 Canada Rickets Market by Causes, 2020 – 2027, (USD Million)

    Table 18 Canada Rickets Market by Therapy, 2020 – 2027, (USD Million)

    Table 19 Canada Rickets Market by End Users, 2020 – 2027, (USD Million)

    Table 20 South America Market by Types, 2020 – 2027, (USD Million)

    Table 21 South America Rickets Market by Causes, 2020 – 2027, (USD Million)

    Table 22 South America Rickets Market by Therapy, 2020 – 2027, (USD Million)

    Table 23 South America Rickets Market by End Users, 2020 – 2027, (USD Million)

    Table 24 Europe Market by Types, 2020 – 2027, (USD Million)

    Table 25 Europe Rickets Market by Causes, 2020 – 2027, (USD Million)

    Table 26 Europe Rickets Market by Therapy, 2020 – 2027, (USD Million)

    Table 27 Europe Rickets Market by End Users, 2020 – 2027, (USD Million)

    Table 28 Western Europe Market by Types, 2020 – 2027, (USD Million)

    Table 29 Western Europe Rickets Market by Causes, 2020 – 2027, (USD Million)

    Table 30 Western Europe Rickets Market by Therapy, 2020 – 2027, (USD Million)

    Table 31 Western Europe Rickets Market by End Users, 2020 – 2027, (USD Million)

    Table 32 Eastern Europe Market by Types, 2020 – 2027, (USD Million)

    Table 33 Eastern Europe Rickets Market by Causes, 2020 – 2027, (USD Million)

    Table 34 Eastern Europe Rickets Market by Therapy, 2020 – 2027, (USD Million)

    Table 35 Eastern Europe Rickets Market by End Users, 2020 – 2027, (USD Million)

    Table 36 Asia Pacific Market by Types, 2020 – 2027, (USD Million)

    Table 37 Asia Pacific Rickets Market by Causes, 2020 – 2027, (USD Million)

    Table 38 Asia Pacific Rickets Market by Therapy, 2020 – 2027, (USD Million)

    Table 39 Asia Pacific Rickets Market by End Users, 2020 – 2027, (USD Million)

    Table 40 Middle East & Africa Market by Types, 2020 – 2027, (USD Million)

    Table 41 Middle East & Africa Rickets Market by Causes, 2020 – 2027, (USD Million)

    Table 42 Middle East & Africa Rickets Market by Therapy, 2020 – 2027, (USD Million)

    Table 43 Middle East & Africa Rickets Market by End Users, 2020 – 2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Rickets Market

    Figure 3 Segmentation Market Dynamics for Global Rickets Market

    Figure 4 Global Rickets market Share, by Type 2020

    Figure 5 Global Rickets market Share, by Causes 2020

    Figure 6 Global Rickets market Share, by Therapy 2020

    Figure 7 Global Rickets Market Share, by End Users, 2020

    Figure 8 Global Rickets Market Share, by Region, 2020

    Figure 9 North America Rickets Market Share, by Country, 2020

    Figure 10 Europe Rickets Market Share, by Country, 2020

    Figure 11 Asia Pacific Rickets Market Share, by Country, 2020

    Figure 12 Middle East & Africa Rickets Market Share, by Country, 2020

    Figure 13 Global Rickets Market: Company Share Analysis, 2020 (%)

    Figure 14 Koninklijke DSM N.V.: Key Financials

    Figure 15 Koninklijke DSM N.V.: Segmental Revenue

    Figure 16 Koninklijke DSM N.V.: Geographical Revenue

    Figure 17 Nestlé S.A.: Key Financials

    Figure 18 Nestlé S.A.: Segmental Revenue

    Figure 19 Nestlé S.A.: Geographical Revenue

    Figure 20 ADM Alliance Nutrition, Inc.: Key Financials

    Figure 21 ADM Alliance Nutrition, Inc.: Segmental Revenue

    Figure 22 ADM Alliance Nutrition, Inc.: Geographical Revenue

    Figure 23 Abbott: Key Financials

    Figure 24 Abbott: Segmental Revenue

    Figure 25 Abbott: Geographical Revenue

    Figure 26 Merck & Co., Inc.: Key Financials

    Figure 27 Merck & Co., Inc.: Segmental Revenue

    Figure 28 Merck & Co., Inc.: Geographical Revenue

    Figure 29 F. Hoffmann-La Roche Ltd.: Key Financials

    Figure 30 F. Hoffmann-La Roche Ltd.: Segmental Revenue

    Figure 31 F. Hoffmann-La Roche Ltd.: Geographical Revenue

    Figure 32 Groupe Danone S.A.: Key Financials

    Figure 33 Groupe Danone S.A.: Segmental Revenue

    Figure 34 Groupe Danone S.A.: Geographical Revenue